Приказ основних података о документу

dc.creatorTadić, Svetlana
dc.creatorNikolić, Katarina
dc.creatorAgbaba, Danica
dc.date.accessioned2019-09-02T11:30:23Z
dc.date.available2019-09-02T11:30:23Z
dc.date.issued2012
dc.identifier.issn1060-3271
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/1760
dc.description.abstractIn this study, the RP-HPLC method was investigated for the separation of citalopram and its four impurities by use of statistical experimental design. Initially, the influence of different experimental conditions (buffer pH, flow rate, and column temperature) on the chromatographic behavior of citalopram and its four impurities was investigated by use of partial least squares regression (PLSR) and multilayer perceptron (MLP) artificial neural networks (ANNs) trained by back-propagation. The developed models and the corresponding response surface plots were used to select the optimal HPLC conditions, buffer pH 7.0, flow rate 1.0 mL/min, and column temperature 25 C, for an efficient separation of citalopram and its four impurities. The elaborated HPLC method was found to be linear, specific, sensitive, precise, accurate, and robust. Retention times of citalopram and its impurities, obtained with the developed HPLC method, and the computed molecular parameters of the examined compounds were used in a quantitative structure retention relationship (QSRR) study. The PLSR and ANN algorithms were applied for the development of the QSRR methods. The MLP-two layers-ANN-QSRR model with root mean square error of prediction 0.105 and r(2) (observed versus predicted) 0.978 was selected. Since many different reaction conditions are applied for the synthesis of citalopram, different impurities and degradation products can be formed. Therefore, the developed QSRR model can be extended to the prediction of the retention times with the other citalopram impurities, degradation products, and metabolites.en
dc.publisherAOAC Int, Gaithersburg
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172033/RS//
dc.rightsrestrictedAccess
dc.sourceJournal of AOAC International
dc.titleDevelopment and Optimization of an HPLC Analysis of Citalopram and Its Four Nonchiral Impurities Using Experimental Design Methodologyen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractТадић, Светлана; Aгбаба, Даница; Николић, Катарина;
dc.citation.volume95
dc.citation.issue3
dc.citation.spage733
dc.citation.epage743
dc.citation.other95(3): 733-743
dc.citation.rankM22
dc.identifier.wos000305366600019
dc.identifier.doi10.5740/jaoacint.SGE_Tadic
dc.identifier.pmid22816264
dc.identifier.scopus2-s2.0-84866443729
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу